FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mario Saltarelli

Research Profile

Chemicals & Drugs

Procedures

Double-Blind Method

Living Beings

Anatomy

Concepts & Ideas

Physiology

Drug Partial Agonism

Co-author Network

Publications

TOP 3
Earle E Bain; Tushar Garimella; James J McGough; Yili Pritchett; Weining Robieson; Walid Abi-Saab; George Apostol; Mario Saltarelli
A randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHD.
Earle E Bain; Dawnelle L McNeill; Weining Z Robieson; Walid Abi-Saab; George Apostol; R Bart Sangal; Mario Saltarelli
A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder.
Robert A Lenz; Charles Locke; Eric G Mohler; Lynne E Rueter; Walid Abi-Saab; Jeffrey D Baker; Keith Wesnes; Mario Saltarelli
The scopolamine model as a pharmacodynamic marker in early drug development.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mario Saltarelli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Earle E Bain; Tushar Garimella; James J McGough; Yili Pritchett; Weining Robieson; Walid Abi-Saab; George Apostol; Mario Saltarelli
A randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHD.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2013;38(3):405-13.
2012: Earle E Bain; Dawnelle L McNeill; Weining Z Robieson; Walid Abi-Saab; George Apostol; R Bart Sangal; Mario Saltarelli
A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder.
The Journal of clinical psychiatry 2012;73(6):783-9.
2012: Robert A Lenz; Charles Locke; Eric G Mohler; Lynne E Rueter; Walid Abi-Saab; Jeffrey D Baker; Keith Wesnes; Mario Saltarelli
The scopolamine model as a pharmacodynamic marker in early drug development.
Psychopharmacology 2012;220(1):97-107.
2012: George Apostol; Michelle A Collins; David Feifel; Laura M Gault; Christopher J Kratochvil; Yili L Pritchett; Weining Z Robieson; Walid Abi-Saab; Lenard A Adler; Mario Saltarelli
Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study.
Psychopharmacology 2012;219(3):715-25.
2011: Laura Redden; Beatrice Rendenbach-Mueller; Walid Abi-Saab; David A Katz; Armen Goenjian; Weining Z Robieson; Yaqin Wang; Sandra L Goss; Nicholas Greco; Mario Saltarelli
A double-blind, randomized, placebo-controlled study of the dopamine D₃ receptor antagonist ABT-925 in patients with acute schizophrenia.
Journal of clinical psychopharmacology 2011;31(2):221-5.
2011: Laura Redden; Yili Pritchett; Weining Robieson; Xenia Kovacs; Mary Garofalo; Katherine Tracy; Mario Saltarelli
Suicidality and divalproex sodium: analysis of controlled studies in multiple indications.
Annals of general psychiatry 2011;10(1):1.
2011: Timothy E Wilens; Laura M Gault; Ann Childress; Christopher J Kratochvil; Lindsey Bensman; Coleen M Hall; Evelyn Olson; Weining Z Robieson; Tushar S Garimella; Walid M Abi-Saab; George Apostol; Mario Saltarelli
Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials.
Journal of the American Academy of Child and Adolescent Psychiatry 2011;50(1):73-84.e1.
2010: Mark Day; Earle Bain; Gerard Marek; Mario Saltarelli; Gerard B Fox
D3 receptor target engagement in humans with ABT-925 using [11C](+)-PHNO PET.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2010;13(3):291-2.
2010: Ariel Graff-Guerrero; Laura Redden; Walid Abi-Saab; David A Katz; Sylvain Houle; Penny Barsoum; Anahita Bhathena; Ramesh Palaparthy; Mario Saltarelli; Shitij Kapur
Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2010;13(3):273-87.
2009: Robert A Lenz; Roy D Elterman; Weining Z Robieson; Namita V Vigna; Mario Saltarelli
Divalproex sodium in children with partial seizures: 12-month safety study.
Pediatric neurology 2009;41(2):101-10.
2009: Evan D Kharasch; Gowdahalli N Subbarao; Keith Richard Cromack; Dennis A Stephens; Mario Saltarelli
Sevoflurane formulation water content influences degradation by Lewis acids in vaporizers.
Anesthesia and analgesia 2009;108(6):1796-802.
2009: Karen Dineen Wagner; Laura Redden; Robert A Kowatch; Timothy E Wilens; Scott Segal; Kiki Chang; Patricia Wozniak; Namita V Vigna; Walid Abi-Saab; Mario Saltarelli
A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.
Journal of the American Academy of Child and Adolescent Psychiatry 2009;48(5):519-32.
2009: Daniel E Casey; David G Daniel; Carol Tamminga; John M Kane; Tram Tran-Johnson; Patricia J Wozniak; Walid Abi-Saab; Jeff Baker; Laura Redden; Nicholas Greco; Mario Saltarelli
Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(5):1330-8.
2009: Laura Redden; Melissa DelBello; Karen Dineen Wagner; Timothy E Wilens; Shishuka Malhotra; Patricia J Wozniak; Namita V Vigna; Nicholas Greco; Xenia Kovacs; Walid Abi-Saab; Mario Saltarelli
Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder.
Journal of child and adolescent psychopharmacology 2009;19(1):83-9.
2009: George Apostol; Donald W Lewis; Genevieve A Laforet; Weining Z Robieson; Julie M Fugate; Walid M Abi-Saab; Mario Saltarelli
Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study.
Headache 2009;49(1):45-53.
2009: George Apostol; Ann Pakalnis; Genevieve A Laforet; Weining Z Robieson; Evelyn Olson; Walid M Abi-Saab; Mario Saltarelli
Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents.
Headache 2009;49(1):36-44.
2008: George Apostol; Roger K Cady; Genevieve A Laforet; Weining Z Robieson; Evelyn Olson; Walid M Abi-Saab; Mario Saltarelli
Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study.
Headache 2008;48(7):1012-25.
2006: Charles L Bowden; Alan C Swann; Joseph Calabrese; Leon M Rubenfaer; Patricia J Wozniak; Michelle A Collins; Walid Abi-Saab; Mario Saltarelli
A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania.
The Journal of clinical psychiatry 2006;67(10):1501-10.
2003: Robert H Dworkin; Misha-Miroslav Backonja; Michael Rowbotham; Robert R Allen; Charles R Argoff; Gary J Bennett; Catherine Bushnell; John T Farrar; Bradley S Galer; Jennifer Haythornthwaite; David J Hewitt; John D Loeser; Mitchell B Max; Mario Saltarelli; Kenneth E Schmader; Christoph Stein; David Thompson; Dennis C Turk; Mark S Wallace; Linda R Watkins; Sharon M Weinstein
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.
Archives of neurology 2003;60(11):1524-34.
1996: Mario Saltarelli; Andrea L Bauman; K R Moore; C C Bradley; Randy D Blakely
Expression of the rat brain creatine transporter in situ and in transfected HeLa cells.
Developmental neuroscience 1996;18(5-6):524-34.
1991: K Yamada; Mario Saltarelli; Joseph T Coyle
[3H]hemicholinium-3 binding in rats with status epilepticus induced by lithium chloride and pilocarpine.
European journal of pharmacology 1991;195(3):395-7.
1991: K Yamada; Mario Saltarelli; Joseph T Coyle
Effects of calmodulin antagonists on sodium-dependent high-affinity choline uptake.
Brain research 1991;542(1):132-4.
1990: Mario Saltarelli; K Yamada; Joseph T Coyle
Phospholipase A2 and 3H-hemicholinium-3 binding sites in rat brain: a potential second-messenger role for fatty acids in the regulation of high-affinity choline uptake.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1990;10(1):62-72.
1989: K Yamada; Mario Saltarelli; Joseph T Coyle
Specificity of the activation of [3H]hemicholinium-3 binding by phospholipase A2.
The Journal of pharmacology and experimental therapeutics 1989;249(3):836-42.
1988: Mario Saltarelli; J Lopez; P R Lowenstein; Joseph T Coyle
The role of calcium in the regulation of [3H]hemicholinium-3 binding sites in rat brain.
Neuropharmacology 1988;27(12):1301-8.
1988: K Yamada; Mario Saltarelli; Joseph T Coyle
Involvement of phospholipase A2 in the regulation of [3H]hemicholinium-3 binding.
Biochemical pharmacology 1988;37(22):4367-73.
1988: K Yamada; Mario Saltarelli; Joseph T Coyle
Solubilization and characterization of a [3H]hemicholinium-3 binding site in rat brain.
Journal of neurochemistry 1988;50(6):1759-64.
1987: Mario Saltarelli; P R Lowenstein; Joseph T Coyle
Rapid in vitro modulation of [3H]hemicholinium-3 binding sites in rat striatal slices.
European journal of pharmacology 1987;135(1):35-40.
1987: Mario Saltarelli; Gianluigi Forloni; M L Oster-Granite; John D Gearhart; Joseph T Coyle
Neurochemical characterization of embryonic brain development in trisomy 19 (Ts19) mice: implications of selective deficits observed for abnormal neural development in aneuploidy.
Developmental genetics 1987;8(4):267-79.
1983: C. Dominique Toran-Allerand; K Hashimoto; William T Greenough; Mario Saltarelli
Sex steroids and the development of the newborn mouse hypothalamus and preoptic area in vitro: III. Effects of estrogen on dendritic differentiation.
Brain research 1983;283(1):97-101.